Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002048
Filing Date
2010-03-11
Accepted
2010-03-11 08:11:03
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2197161z10-k.htm 10-K 1192267
2 EXHIBIT 10.29 a2197161zex-10_29.htm EX-10.29 86694
3 EXHIBIT 10.30 a2197161zex-10_30.htm EX-10.30 64985
4 EXHIBIT 10.31 a2197161zex-10_31.htm EX-10.31 65696
5 EXHIBIT 23.1 a2197161zex-23_1.htm EX-23.1 4097
6 EXHIBIT 23.2 a2197161zex-23_2.htm EX-23.2 4386
7 EXHIBIT 31.1 a2197161zex-31_1.htm EX-31.1 7995
8 EXHIBIT 31.2 a2197161zex-31_2.htm EX-31.2 8041
9 EXHIBIT 32.1 a2197161zex-32_1.htm EX-32.1 4978
10 G587233.JPG g587233.jpg GRAPHIC 68343
  Complete submission text file 0001047469-10-002048.txt   1534671
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 10672354
SIC: 2834 Pharmaceutical Preparations